These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 19666145)

  • 1. Dystonia and deafness due to SUCLA2 defect; Clinical course and biochemical markers in 16 children.
    Morava E; Steuerwald U; Carrozzo R; Kluijtmans LA; Joensen F; Santer R; Dionisi-Vici C; Wevers RA
    Mitochondrion; 2009 Nov; 9(6):438-42. PubMed ID: 19666145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SUCLA2 mutations are associated with mild methylmalonic aciduria, Leigh-like encephalomyopathy, dystonia and deafness.
    Carrozzo R; Dionisi-Vici C; Steuerwald U; Lucioli S; Deodato F; Di Giandomenico S; Bertini E; Franke B; Kluijtmans LA; Meschini MC; Rizzo C; Piemonte F; Rodenburg R; Santer R; Santorelli FM; van Rooij A; Vermunt-de Koning D; Morava E; Wevers RA
    Brain; 2007 Mar; 130(Pt 3):862-74. PubMed ID: 17301081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [SUCLA2-related encephalomyopathic mitochondrial DNA depletion syndrome: a case report and review of literature].
    Liu Z; Fang F; Ding C; Wu H; Lyu J; Wu Y
    Zhonghua Er Ke Za Zhi; 2014 Nov; 52(11):817-21. PubMed ID: 25582465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial encephalomyopathy with elevated methylmalonic acid is caused by SUCLA2 mutations.
    Ostergaard E; Hansen FJ; Sorensen N; Duno M; Vissing J; Larsen PL; Faeroe O; Thorgrimsson S; Wibrand F; Christensen E; Schwartz M
    Brain; 2007 Mar; 130(Pt 3):853-61. PubMed ID: 17287286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel SUCLA2 mutation in a Portuguese child associated with "mild" methylmalonic aciduria.
    Nogueira C; Meschini MC; Nesti C; Garcia P; Diogo L; Valongo C; Costa R; Videira A; Vilarinho L; Santorelli FM
    J Child Neurol; 2015 Feb; 30(2):228-32. PubMed ID: 24659738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Succinate-CoA ligase deficiency due to mutations in SUCLA2 and SUCLG1: phenotype and genotype correlations in 71 patients.
    Carrozzo R; Verrigni D; Rasmussen M; de Coo R; Amartino H; Bianchi M; Buhas D; Mesli S; Naess K; Born AP; Woldseth B; Prontera P; Batbayli M; Ravn K; Joensen F; Cordelli DM; Santorelli FM; Tulinius M; Darin N; Duno M; Jouvencel P; Burlina A; Stangoni G; Bertini E; Redonnet-Vernhet I; Wibrand F; Dionisi-Vici C; Uusimaa J; Vieira P; Osorio AN; McFarland R; Taylor RW; Holme E; Ostergaard E
    J Inherit Metab Dis; 2016 Mar; 39(2):243-52. PubMed ID: 26475597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The severity of phenotype linked to SUCLG1 mutations could be correlated with residual amount of SUCLG1 protein.
    Rouzier C; Le Guédard-Méreuze S; Fragaki K; Serre V; Miro J; Tuffery-Giraud S; Chaussenot A; Bannwarth S; Caruba C; Ostergaard E; Pellissier JF; Richelme C; Espil C; Chabrol B; Paquis-Flucklinger V
    J Med Genet; 2010 Oct; 47(10):670-6. PubMed ID: 20693550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel mutation in SUCLA2 identified on sequencing analysis.
    Güngör O; Özkaya AK; Güngör G; Karaer K; Dilber C; Aydin K
    Pediatr Int; 2016 Jul; 58(7):659-61. PubMed ID: 26952923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of 3-methylglutaconic aciduria with sensori-neural deafness, encephalopathy, and Leigh-like syndrome (MEGDEL association) in four patients with a disorder of the oxidative phosphorylation.
    Wortmann S; Rodenburg RJ; Huizing M; Loupatty FJ; de Koning T; Kluijtmans LA; Engelke U; Wevers R; Smeitink JA; Morava E
    Mol Genet Metab; 2006 May; 88(1):47-52. PubMed ID: 16527507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The novel mutation p.Asp251Asn in the β-subunit of succinate-CoA ligase causes encephalomyopathy and elevated succinylcarnitine.
    Jaberi E; Chitsazian F; Ali Shahidi G; Rohani M; Sina F; Safari I; Malakouti Nejad M; Houshmand M; Klotzle B; Elahi E
    J Hum Genet; 2013 Aug; 58(8):526-30. PubMed ID: 23759946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Succinyl-CoA synthetase (SUCLA2) deficiency in two siblings with impaired activity of other mitochondrial oxidative enzymes in skeletal muscle without mitochondrial DNA depletion.
    Huang X; Bedoyan JK; Demirbas D; Harris DJ; Miron A; Edelheit S; Grahame G; DeBrosse SD; Wong LJ; Hoppel CL; Kerr DS; Anselm I; Berry GT
    Mol Genet Metab; 2017 Mar; 120(3):213-222. PubMed ID: 27913098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel SUCLA2 Mutation Presenting as a Complex Childhood Movement Disorder.
    Garone C; Gurgel-Giannetti J; Sanna-Cherchi S; Krishna S; Naini A; Quinzii CM; Hirano M
    J Child Neurol; 2017 Feb; 32(2):246-250. PubMed ID: 27651038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SUCLA2 Deficiency: A Deafness-Dystonia Syndrome with Distinctive Metabolic Findings (Report of a New Patient and Review of the Literature).
    Maas RR; Marina AD; de Brouwer AP; Wevers RA; Rodenburg RJ; Wortmann SB
    JIMD Rep; 2016; 27():27-32. PubMed ID: 26409464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical, Molecular, and Computational Analysis in two cases with mitochondrial encephalomyopathy associated with SUCLG1 mutation in a consanguineous family.
    Maalej M; Tej A; Bouguila J; Tilouche S; Majdoub S; Khabou B; Tabbebi M; Felhi R; Ammar M; Mkaouar-Rebai E; Keskes L; Boughamoura L; Fakhfakh F
    Biochem Biophys Res Commun; 2018 Jan; 495(2):1730-1737. PubMed ID: 29217198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sepiapterin reductase deficiency an autosomal recessive DOPA-responsive dystonia.
    Abeling NG; Duran M; Bakker HD; Stroomer L; Thöny B; Blau N; Booij J; Poll-The BT
    Mol Genet Metab; 2006; 89(1-2):116-20. PubMed ID: 16650784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disorders caused by deficiency of succinate-CoA ligase.
    Ostergaard E
    J Inherit Metab Dis; 2008 Apr; 31(2):226-9. PubMed ID: 18392745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-occurring Down syndrome and SUCLA2-related mitochondrial depletion syndrome.
    Couser NL; Marchuk DS; Smith LD; Arreola A; Kaiser-Rogers KA; Muenzer J; Pandya A; Gucsavas-Calikoglu M; Powell CM
    Am J Med Genet A; 2017 Oct; 173(10):2720-2724. PubMed ID: 28749033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in SUCLA2: a tandem ride back to the Krebs cycle.
    Chinnery PF
    Brain; 2007 Mar; 130(Pt 3):606-9. PubMed ID: 17347254
    [No Abstract]   [Full Text] [Related]  

  • 19. A de novo missense mutation in a critical domain of the X-linked DDP gene causes the typical deafness-dystonia-optic atrophy syndrome.
    Tranebjaerg L; Hamel BC; Gabreels FJ; Renier WO; Van Ghelue M
    Eur J Hum Genet; 2000 Jun; 8(6):464-7. PubMed ID: 10878669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial encephalomyopathy and retinoblastoma explained by compound heterozygosity of SUCLA2 point mutation and 13q14 deletion.
    Matilainen S; Isohanni P; Euro L; Lönnqvist T; Pihko H; Kivelä T; Knuutila S; Suomalainen A
    Eur J Hum Genet; 2015 Mar; 23(3):325-30. PubMed ID: 24986829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.